Chemical Structure (Image 01)
Amantadine Hydrochloride
Product Images NDC 50383-807
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amantadine Hydrochloride (NDC 50383-807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table (Image 02)
This is a dosage guideline for administering Amantadine Hydrochloride based on the patient's creatinine clearance rate in mL/min/1.73 m2. The recommended initial dose for patients with a clearance rate between 30-50 is 200mg, followed by a daily maintenance dose of 100mg. For patients with a clearance rate of 15 - 29 mL/min/1.73 m2, the recommendation is to an initial dose of 200mg followed by 100 mg administered on alternatingdays. Finally, for patients with a clearance rate of less than 15 mL/min/1.73 m2, the recommended dose is 200mg every 7 days.*
Display Panel (Image 03)
This is a medication called Amantadine, in liquid form with a concentration of 50 mg per 5 ml. The usual dosage is indicated in the package insert. It should be stored tightly closed, and at a temperature of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). The medication is prescribed and dispensed in the original container with a child-resistant closure, and the label shows the manufacturer as LTI HLTECH PHARMACAL CO. The NDC code is 50383-807-16 and the product comes in a 16 fl oz (473 mL) bottle.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
